| Also known as |
Lansox, Takepron, Agopton |
| Blood pressure |
Generally has no effect on blood pressure |
| Chemical name |
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
| Dosage (medical) |
15 mg to 30 mg daily |
| Dosage (sports) |
Not applicable |
| Effects |
Decreases gastric acid secretion |
| Formula |
C16H14F3N3O2S |
| Half-life |
1 to 1.5 hours |
| Hepatotoxicity |
Rare, but some cases have been reported |
| Lab Test |
Not regularly required in treatment monitoring |
| Main action |
Reduces stomach acid production |
| Side effects |
Headache, diarrhea, abdominal pain, nausea, dizziness |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
30 mg |
| Substance class |
Proton pump inhibitor |
| Trade name |
Prevacid |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Cipla |
